Erratum: Turn me on: Regulating HIF transcriptional activity (Cell Death and Differentiation (2008) 10.1038/sj.cdd.4402315);Turn me on: Regulating HIF transcriptional activity

Cell Death and Differentiation

Volumn 15, Issue 4, 2008, Pages 642-649

  Lisy, K ^a   Peet, D J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINYL HYDROXYLASE; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; OXYGENASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CELL SPECIFICITY; DNA BINDING; GENE CONTROL; HUMAN; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; TISSUE SPECIFICITY;

EID: 40949132841     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402308     Document Type: Erratum

References (68)

1. 2 tension. Proc Natl Acad Sci USA 1995; 92: 5510-5514.
2. Bracken CP, Whitelaw ML, Peet DJ. The hypoxia-inducible factors: Key transcriptional regulators of hypoxic responses. Cell Mol Life Sci 2002; 60: 1376-1393.
3. 2 tension. Am J Physiol 1996; 271: C1172-C1180.
4. Gu YZ, Moran SM, Hogenesch JB, Wartman L, Bradfield CA. Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha. Gene Expr 1998; 7: 205-213.
5. Makino Y, Cao R, Svensson K, Bertilsson G, Asman M, Tanaka H et al Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 2001; 414: 550-554.
6. Makino Y, Kanopka A, Wilson WJ, Tanaka H, Poellinger L. Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3alpha locus. J Biol Chem 2002; 277 32405-32408.
7. Heidbreder M, Frohlich F, Johren O, Dendorfer A, Oadri F, Dominlak P. Hypoxia rapidly activates HIF-3alpha mRNA expression. FASEB J 2003; 17: 1541-1543.
8. Huang LE, Arany Z, Livingston DM, Bunn HF. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem 1996; 271: 32253-32239.
9. Yu AY, Frid MG, Shimoda LA, Wiener CM, Stenmark K, Semenza GL. Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. Am J Physiol 1998; 275: L818-L826.
10. Liu YV, Semenza GL. RACK1 vs HSP90: Competition for HIF-I alpha degradation vs stabilization. Cell Cycle 2007; 6: 656-659.
11. Chapman-Smith A, Whitelaw ML. Novel DNA binding by a basic helix-loop-helix protein. The role of the dioxin receptor PAS domain. J Biol Chem 2006; 281: 12535-12545.
12. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992; 12: 5447-5454.
13. Kimura H, Weisz A, Ogura T, Hitomi Y, Kurashima Y, Hashimoto K et al Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J Biol Chem 2001; 276: 2292-2298.
14. Elvidge GP, Glenny L, Appelhoff RJ, Ratcliffe PJ, Ragoussis J, Gleadle JM. Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: The role of HIF-1alpha, HIF-2alpha, and other pathways. J Biol Chem 2006; 281: 15215-15226.
15. Jiang BH, Zheng JZ, Leung SW, Roe R, Somenza GL. Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension. J Biol Chem 1997; 272: 19253-19260.
16. Pugh CW, O'Rourke JF, Nagao M, Gleadle JM, Ratcliffe PJ. Activation of hypoxia-inducible factor definition of regulatory domains within the alpha subunit. J Biol Chem 1997; 272: 11205-11214.
17. Dayan F, Roux D, Brahimi-Hom MC, Pouyssegur J, Mazure NM. The oxygen sensor factor inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1 alpha. Cancer Res 2006; 66 3688-3698.
18. Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA et al. An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci USA 1996; 93: 12969-12973.
19. Ema M, Hirota K, Mimura J, Abe H, Yodoi J, Sogawa K et al. Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: Their stabilization and redox signal-induced Interaction with CBP/p300. EMBO J 1999; 18:1905-1914.
20. Carrero P, Okamoto K, Coumaillaeu P. O'Brian S, Tanaka H, Poellinger L. Redox regulated recruitment of the transcriptional coactivitors CREB-binding protien and SRC-1 to hypoxia-inducible factor 1alpha. Mol Cell Biol 2000; 20: 402-405.
21. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 2002; 295:858-861.
22. Beischlag TV, Taylor RT, Rose DW, Yoon D, Chen Y, Lee WH et al. Recruitment of thyroid hormone receptor/retinoblastoma-interacting protein 230 by the aryl hydrocarbon receptor nuclear translocator is required for the transcriptional response to-both dioxin and hypoxia. J Biol Chem 2004; 279: 54620-54628.
23. Hu CJ, Sataur A, Wang L, Chen H, Simon MC. The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1 alpha and HIF-2alpha. Mol Biol Cell 2007; 18: 4528-4542.
24. O'Rourke JF, Tian YM, Ratcliffe PJ, Pugh CW. Oxygen-regulated and transactivating domains in endothelial PAS protein 1: Comparison with hypoxia-inducible factor-1alpha. J Biol Chem 1999; 274: 2060-2071.
25. Lando D, Poet DJ, Gorman JJ, Whelan DA, Whitelow ML, Bruick RK. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 2002; 16: 1466-1471.
26. Mahon PC, Hirota K, Semenza GL. FIH-1: A novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 2001: 15: 2675-2686.
27. Hewitson KS, McNeill LA, Riordan MV, Tian YM, Bullock AN, Welford RW et al. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J Biol Chem 2002; 277: 26351-26355.
28. Hewitson KS, McNeill LA, Elkins JM, Schofield CJ. The role of iron and 2-oxoglutarate oxygenases in signalling. Biochem Soc Trans 2003; 31: 510-515.
29. Koivunen P, Hirsila M, Gunzler V, Kivirikko KI, Myllyharju J. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J Biol Chem 20134; 279: 9899-9904.
30. Hirsila M, Koivunen P, Gunzler V, Kivirikko KI, Myllyharju J. Characterization of the human prolyi 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem 2003; 276: 30772-30780; e-pub 2003 June 3.
31. Schofield CJ, Ratcliffe PJ. Signalling hypoxia by HIF hydroxylases. Biochem Biophys Res Commu 2005; 338: 617-626.
32. Fandrey J, Gorr TA, Gassmann M. Regulating cellular oxygen sensing by hydroxylation. Cardiovasc Res 2006; 71: 642-651.
33. Bell EL, Chandell NS. Mitochondrial oxygen sensing: Regulation of hypoxia-inducible factor by mitochondrial generated reactive oxygen species. Essays Biochem 2007; 43: 17-27.
34. Stolze IP, Tian YM, Appellhoff RJ, Turley H, Wykoff CC, Gleadle JM et al. Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (HIF) in regulating HIF transcriptional target genes. J Biol Chem 2004; 279 42719-42725.
35. Ehrismann D, Flashman E, Genn DN, Mathioudakis N, Hewitson KS, Ratcliffe PJ et al. Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay. Biochom J 2007; 401: 227-234.
36. Bracken CP, Fedele AO, Linke S, Belrak W, Lisy K, Whitelaw ML et al Cell-specific regulation of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha stabilization and transactivation in a graded oxygen environment. J Biol Chem 2006; 281: 22575-22585.
37. Dames SA, Martinez-Yamout M, Do Guzman RN, Dyson HJ, Wright PE. Structural basis for Hif-1 alpha/CBP recognition in the cellular hypoxic response. Proc Natl Acad Sci USA 2002; 99:5271-5276.
38. Freedman SJ, Sun ZY, Poy F, Kung AL, Livingston DM, Wagner G et al Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha. Proc Natl Acad Sci USA 2002; 99: 5367-5372.
39. Elkins JM, Hewitson KS, McNeill LA, Seibel JF, Schlemminger I, Pugh CW et al, Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 alpha. J Biol Chem 2003; 278: 1802-1806.
40. Linke S, Stojkoski C, Kewley RJ, Booker GW, Whitelaw ML, Peet DJ. Substrate requirements of the oxygen-sensing asparaginyl hydroxylase factor-inhibiting hypoxia-inducible factor. Biol Chem 2004; 279 14391-14397.
41. Cho H, Ahn DR, Park H, Yang EG. Modulation of p300 binding by posttranslational modifications of the C-terminal activation domain of hypoxia-inducible factor-1alpha. FESS Lett 2007; 581: 1542-1548.
42. Soilleux EJ, Turley H, Tian YM, Pugh CW, Gatter KC, Harris AL. Use of novel monoclonal antibodies to determine the expression and distribution of the hypoxia regulatory factors PHD-1, PHD-2, PHD-3 and FIH in normal and neoplastic human tissues. Histopathology 2005; 47: 602-610.
43. Metzen E, Berchner-Pfannschmidt U, Stengel P, Marxsen JH, Stolze I, Klinger M et al. Intracellular localisation of human HIF-1 alpha hydroxylases: Implications for oxygen sensing. J Cell Sci 2003; 116: 1319-1326.
44. Cockman ME, Lancaster DE, Stolze IP, Hewitson KS, McDonough MA, Coleman ML et al. Posttranslational hydroxylation of ankyrin repeats in lkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase factor inhibiting HIF (FIH). Proc Natl Acad Sci US4 2006; 103: 14767-14772.
45. Coleman ML, McDonough MA. Hewitson K.S, Coles C, Mecinovic J, Edelmsnn M et al. Aparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor. J Biol Chem 2007; 282: 24027-24038.
46. Ferguson III JE, Wu Y. Smith K, Charles P, Power K, Wang H et al. ABS4 is a hydroxylation substrate of FIH and promotes vascular differentation via an oxygen dependent mechanism. Mol Cell Biol 2007; 27: 6407-6419.
47. Fukuba H, Yamashita H, Nagano Y, Jin HG, Hiji M, Ohtsuki T et al. Siah-1 facilitates ubiquitination and degradation of factor inhibiting HIF-1alpha (FIH). Biochem Biophys Res Commun 2007; 353: 324-329.
48. Li J, Wang E, Dutta S, Lau JS, Jiang SW, Delta K at al. Protein kinase C-mediated modulation of FIH-1 expression by the homeodomain protein CDP/Cut/Cux. Mol Cell Biol 2007; 27: 7345-7353.
49. Koivunen P, Hirsila M, Kivirikko KI, Myllyharju J. The length of peptide substrates has a marked effect on hydroxylation by the hypoxia-inducible factor prolyl 4-hydroxylases. J Biol Chem 2006; 281: 28712-28720.
50. Hewitson KS, Lienard BM, McDonough MA, Clifton U, Buffer D, Soares AS et al. Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricboxylic acid cycle intermediates. J Biol Chem 2007; 282: 3293-3301.
51. Gradin K, Takasaki C, Fujii-Kuriyama Y, Sogawa K. The transcriptional activation function of the HIF-like factor requires phosphorylation at a conserved threonine. J Biol Chem 2002; 277:23508-23514.
52. Lancaster DE, McNeill LA, McDonough MA, Aplin RT, Hewitson KS, Pugh CW et al. Disruption of dimerization and substrate phosphorylation inhibit factor inhibiting hypoxia- inducible factor (FIH) activity. Biochem J 2004; 363: 429-437.
53. Peet D, Links S. Regulation of HIF: Asparaginyl hydroxylation. Novartis Found Symp 2006; 272: 37-49, 50-53, 131-140.
54. Sang N, Stiehl DP, Bohensky J, Leshchinsky I, Srinivas V, Caro J. MAPK signaling upregulates the activity of hypoxia-inducible factors by its effects on p300. J Biol Chem 2003; 278: 14013-14019.
55. Mylonis I, Chachami G, Samiotaki M, Panayotou G, Paraskova E, Kalousi A et al. Identification of MAPK phosphorylation sites and their role in the localization and activity of hypoxia-inducible factor alpha. J Biol Chem 2006; 261: 33095-33106.
56. Yasinska IM, Sumbayev VV. S-nitrosation of Cys-800 of HIF-1alpha protein activates its interaction with p300 and stimulates its transcriptional activity. FESS Lett 2003, 549: 105-109.
57. Carbia-Nagashima A, Gerez J, Perez-Castro C, Paez-Pereda M, Silberstein S, Stalla GK et al. RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia. Cell 2007; 131: 309-323.
58. Bae SH, Jeong JW, Park JA, Kim SH, Bae MK, Choi et al. Sumoylation increases HIF-1alpha stability and its transcriptional activity. Biochem, Biophys Res Commun 2004; 324: 394-400.
59. Berta MA, Mazure N, Hattab M, Pouyssegur J, Brahimi-Hom MG. SUMOylation of hypoxia-inducible factor alpha reduces its transcriptional activity. Biochem Biophys Res Commun 2007; 360: 646-652.
60. Cheng J, Kang X, Zhang S, Yeh ET. SUMO-specific protease 1 essential for stabilization of HIF1alpha during hypoxia. Cell 2007; 131: 584-595.
61. Bracken CP, Whitelaw ML, Peet DJ. Activity of hypoxia-inducible factor 2alpha is regulated by association with the NF-kappaB essential modulator. J Biol Chem 2005; 280: 14240-14251.
62. Elvert G, Kappel A, Heidenreich R, Englmeier U, Lanz S, Acker T et al Cooperative interaction of hypoxia-inducible factor-2alpha(HIF-2alpha) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor (Flk-1). J Biol Chem 2003; 278: 7520-7530.
63. Zhang W, Tsuchiya T, Yasukochi Y. Transitional change in interaction between HIF-1 and HNF4 in response to hypoxia. J Hum Genet 1999; 44: 293-299.
64. Tsuchiya T, Kominato Y, Ueda M. Human hypoxic signal transduction through a siginature motif in hepatocyte nuclear factor 4. J Biochem (Tokyo) 2002; 132: 37-44.
65. Sanchez-Elsner T, Botella LM, Velasco B, Corbi A, Attisano L, Bemabeu C. Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J Biol Chem 2001; 275: 38527-39535.
66. Gray MJ, Zhang J, Ellis LM, Semenza GL, Evans DB, Watowich SS et al HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene 2005; 24: 3110-3120.
67. Gustafsson MV, Zheng X, Pereira T, Gradin K. Jin S, Lundkvist J et al Hypoxia requires notch signaling to maintain the undifferentiated call state. Dev Cell 2005; 9: 617-628.
68. Katschinski DM, Le L, Schindler SG, Thomas T, Voss AK, Wenger RH. Interaction of the PAS B domain with HSP90 accelerates hypoxia-inducible factor-1alpha stabilization. Cell Physiol Biochem 2004; 14: 351-360.